亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Warfarin Dose Adjustment During Rifampicin Therapy: A Case Report with Practical Monitoring Implications

医学 利福平 华法林 麻醉 药理学 重症监护医学 药代动力学 梅德林 内科学 抗生素 药品 毒性 外科 心房颤动
作者
Xi Li,Liying Wu,Xiaohua Liu,Pengmei Li,Li Zhao
出处
期刊:Journal of Visualized Experiments [MyJOVE]
卷期号: (234)
标识
DOI:10.3791/73270
摘要

Warfarin management is challenging because its anticoagulant effect is influenced by drug-drug interactions and individual variability. Rifampicin is a potent inducer of cytochrome P450 enzymes and can substantially reduce warfarin efficacy, making structured monitoring and individualized dose adjustment necessary. This report aimed to describe the clinical management strategy for maintaining therapeutic anticoagulation in a patient receiving concurrent warfarin and rifampicin therapy, with a focus on International Normalized Ratio (INR) monitoring, dose adjustment, and pharmacist-led management. We present a clinical case of a 64-year-old Chinese male with chronic thromboembolic pulmonary hypertension who required long-term warfarin therapy and subsequently received rifampicin-containing antituberculosis treatment. The patient's clinical course, INR values, warfarin dose adjustments, and safety outcomes were retrospectively reviewed. A structured pharmacist-supported monitoring approach was applied during rifampicin co-administration. After rifampicin initiation, the patient's warfarin requirement increased from 1.5 mg/day to 4.5 mg/day, representing an approximately 200% increase. INR was monitored twice weekly during the initial phase and subsequently weekly until stabilization. A therapeutic INR range (2-3) was achieved after approximately 2 months without thromboembolic events or major bleeding complications. Rifampicin-warfarin co-administration requires individualized management rather than fixed dose adjustment strategies. Frequent INR monitoring, timely dose modification, and pharmacist involvement may facilitate safe maintenance of anticoagulation during this clinically significant drug-drug interaction.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
wwwyyy完成签到,获得积分10
3秒前
共享精神的应助被gurdeva采纳,获得10
3秒前
4秒前
挚友发布了新的文献求助10
5秒前
小太阳完成签到,获得积分10
6秒前
6秒前
gqz发布了新的文献求助10
6秒前
LukaMagic完成签到,获得积分10
8秒前
飞天大南瓜完成签到,获得积分10
9秒前
英姑的应助被once采纳,获得30
9秒前
yangzai完成签到 ,获得积分0
10秒前
10秒前
美满惜雪发布了新的文献求助10
11秒前
在水一方的应助被gqz采纳,获得10
13秒前
13秒前
gurdeva发布了新的文献求助10
15秒前
辞屿完成签到,获得积分10
15秒前
繁荣的玲完成签到,获得积分10
17秒前
如意厉完成签到,获得积分10
17秒前
星辰大海的应助被美满惜雪采纳,获得10
18秒前
19秒前
慕青的应助被辞屿采纳,获得10
20秒前
yueyue发布了新的文献求助10
22秒前
所所的应助被飘逸小之采纳,获得10
24秒前
搜集达人的应助被fff采纳,获得10
26秒前
33秒前
充电宝的应助被多多采纳,获得10
34秒前
37秒前
39秒前
40秒前
44秒前
单薄的白翠完成签到,获得积分10
45秒前
45秒前
46秒前
9898发布了新的文献求助10
47秒前
48秒前
开放的子默完成签到,获得积分10
48秒前
49秒前
比奥利奥还奥的美少女完成签到 ,获得积分10
50秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184945
求助须知:如何正确求助?哪些是违规求助? 9573899
关于积分的说明 21833591
捐赠科研通 7782403
什么是DOI,文献DOI怎么找? 3434429
关于科研通互助平台的介绍 2558672
邀请新用户注册赠送积分活动 2481161